Literature DB >> 827761

EEG and behavioral effects of delta9-tetrahydrocannabinol in combination with stimulant drugs in rabbits.

P Consroe, B Jones, H Laird.   

Abstract

In rabbits, delta9-tetrahydrocannabinol (THC) at 0.5 mg/kg i.v., was challenged with i.v. methamphetamine (0.1 mg/kg), cocaine (1 mg/kg), apomorphine (1 mg/kg), or caffeine (12.5 mg/kg), and observations were made on quantified EEG and behavior. Cortical and hippocampal alterations produced by THC were antagonized by methamphetamine, cocaine, and caffeine and only briefly by apomorphine. Postural and activity behaviors were reversed by methamphetamine and caffeine but only briefly by cocaine and apomorphine. Additionally, stereotypy resulted from the combination of THC with methamphetamine, cocaine, or apomorphine. These data indicate that the effects of THC were antagonized by stimulant drugs of which caffeine was the most effective. However, novel toxicity also resulted from the interaction of THC with catecholaminergic drugs.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 827761     DOI: 10.1007/BF00634153

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Some pharmacological effects of two tetrahydrocannabinols.

Authors:  R DAGIRMANJIAN; E S BOYD
Journal:  J Pharmacol Exp Ther       Date:  1962-01       Impact factor: 4.030

Review 2.  Catecholamines in the brain as mediators of amphetamine psychosis.

Authors:  S H Snyder
Journal:  Arch Gen Psychiatry       Date:  1972-08

3.  Stereotyped and non-stereotyped behaviour in rats induced by various stimulant drugs.

Authors:  R Fog
Journal:  Psychopharmacologia       Date:  1969

4.  Cannabinoid induced changes in mouse striatal homovanillic acid and dihydroxyphenylacetic acid: the effects of amphetamine and L-dopa.

Authors:  P Osgood; J Howes
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1974-12

5.  Antagonism of amphetamine locomotor stimulation in rats by single doses of marijuana extract administered orally.

Authors:  J H Pirch; R A Cohn; K C Osterholm; E S Barratt
Journal:  Neuropharmacology       Date:  1973-05       Impact factor: 5.250

6.  On the mode of action of apomorphine.

Authors:  B Costall; R J Naylor
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

7.  Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists.

Authors:  K Fuxe; U Ungerstedt
Journal:  Med Biol       Date:  1974-02

8.  Psychopharmacology of amphetamines.

Authors:  J M van Rossum
Journal:  Psychiatr Neurol Neurochir       Date:  1972 May-Jun

Review 9.  General pharmacological actions of some synthetic tetrahydrocannabinol derivatives.

Authors:  H F Hardman; E F Domino; M H Seevers
Journal:  Pharmacol Rev       Date:  1971-12       Impact factor: 25.468

10.  Modification of sympathetic function. Indirectly acting sympathomimetic amines.

Authors:  E Muscholl
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

View more
  2 in total

1.  Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.

Authors:  Vasco C Sousa; Natália Assaife-Lopes; Joaquim A Ribeiro; Judith A Pratt; Ros R Brett; Ana M Sebastião
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

Review 2.  Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.

Authors:  John M McPartland; Geoffrey W Guy; Vincenzo Di Marzo
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.